Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine

被引：0
|
作者：
Aaron J. Schueneman
Elizabeth A. Sugar
Jennifer Uram
Elaine Bigelow
Joseph M. Herman
Barish H. Edil
Elizabeth M. Jaffee
Lei Zheng
Daniel A. Laheru
机构：
[1] Johns Hopkins University School of Medicine,Department of Oncology
[2] Johns Hopkins University School of Medicine,Department of Medicine
[3] Johns Hopkins University School of Medicine,Department of Surgery
[4] Johns Hopkins University School of Medicine,Department of Radiation Oncology
[5] Johns Hopkins University School of Medicine,The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care
[6] Johns Hopkins University School of Medicine,The Sol Goldman Pancreatic Cancer Center
[7] Johns Hopkins University,Departments of Biostatistics and Epidemiology, Bloomberg School of Public Health
[8] University of Colorado,Pancreas and Biliary Surgery Program, Department of Surgery
来源：
Annals of Surgical Oncology | 2013年 / 20卷
关键词：
Overall Survival; Pancreatic Cancer; Complete Blood Count; Lymphocyte Count; Ipilimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：725 / 730
页数：5
相关论文
共 50 条
  • [21] Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
    Li, Debang
    Hu, Bin
    Zhou, Yanming
    Wan, Tao
    Si, Xiaoying
    BMC CANCER, 2018, 18
  • [22] Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
    Debang Li
    Bin Hu
    Yanming Zhou
    Tao Wan
    Xiaoying Si
    BMC Cancer, 18
  • [23] Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
    Mahajan, Ujjwal Mukund
    Langhoff, Eno
    Goni, Elisabetta
    Costello, Eithne
    Greenhalf, William
    Halloran, Christopher
    Ormanns, Steffen
    Kruger, Stephan
    Boeck, Stefan
    Ribback, Silvia
    Beyer, Georg
    Dombroswki, Frank
    Weiss, Frank-Ulrich
    Neoptolemos, John P.
    Werner, Jens
    D'Haese, Jan G.
    Bazhin, Alexandr
    Peterhansl, Julian
    Pichlmeier, Svenja
    Buechler, Markus W.
    Kleeff, Joerg
    Ganeh, Paula
    Sendler, Matthias
    Palmer, Daniel H.
    Kohlmann, Thomas
    Rad, Roland
    Regel, Ivonne
    Lerch, Markus M.
    Mayerle, Julia
    GASTROENTEROLOGY, 2018, 155 (05) : 1625 - +
  • [24] Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Morimachi, Masashi
    Hirabayashi, Kenichi
    Takanashi, Yumi
    Kawanishi, Aya
    Saika, Tsubasa
    Ueyama, Yumiko
    Nakagohri, Toshio
    Nakamura, Naoya
    Suzuki, Hidekazu
    Kagawa, Tatehiro
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (11) : 741 - 745
  • [25] Survival in Patients Aged 75 Years and Older Receiving Adjuvant Chemoradiation for Resected Pancreatic Adenocarcinoma: A Multicenter, Multinational Pooled Analysis
    Maidment, B. W., III
    Mattiucci, G. C.
    Falconi, M.
    van Stiphout, R. G. P. M.
    Alfieri, S.
    Calvo, F. A.
    Herman, J. M.
    Miller, R. C.
    Regine, W. F.
    Reni, M.
    Sharma, N. K.
    Partelli, S.
    Genovesi, D.
    Balducci, M.
    Deodato, F.
    Valentini, V.
    Morganti, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E149 - E149
  • [26] An Increased Number of Perineural Invasions Is Independently Associated With Poor Survival of Patients With Resectable Pancreatic Ductal Adenocarcinoma
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Hashimoto, Yasushi
    Nakagawa, Naoya
    Sasaki, Hayato
    Sueda, Taijiro
    PANCREAS, 2015, 44 (08) : 1345 - 1351
  • [27] A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas
    Laheru, D.
    Yeo, C.
    Biedrzycki, B.
    Solt, S.
    Lutz, E.
    Onners, B.
    Tartakovsky, I.
    Herman, J.
    Hruban, R.
    Piantadosi, S.
    Jaffee, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival
    Pergolini, Ilaria
    Morales-Oyarvide, Vicente
    Mino-Kenudson, Mari
    Honselmann, Kim C.
    Rosenbaum, Matthew W.
    Nahar, Sabikun
    Kem, Marina
    Ferrone, Cristina R.
    Lillemoe, Keith D.
    Bardeesy, Nabeel
    Ryan, David P.
    Thayer, Sarah P.
    Warshaw, Andrew L.
    Fernandez-del Castillo, Carlos
    Liss, Andrew S.
    PLOS ONE, 2017, 12 (08):
  • [29] Time From Diagnosis to Chemotherapy Initiation Is Not Associated with Survival Among Patients Receiving Neoadjuvant Therapy for Pancreatic Adenocarcinoma
    Hue, Jonathan J.
    Sugumar, Kavin
    Rothermel, Luke
    Ammori, John B.
    Hardacre, Jeffrey M.
    Winter, Jordan M.
    Ocuin, Lee M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : E124 - E124
  • [30] Vaccine-associated immune and WT-1 responses are associated with better relapse-free survival in patients with AML in remission treated with a GM-CSF secreting leukemia vaccine and autologous stem cell transplant (ASCT).
    Borrello, I
    Levitsky, H
    Damon, L
    Linker, C
    Deangelo, D
    Alyea, E
    Stock, W
    Sher, D
    Donnelly, A
    Hege, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 569S - 569S
12345